[{"Assets_0_FY_USD":109314000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":2.01,"EarningsPerShareBasic_4_FY_USD":3.15,"EarningsPerShareDiluted_4_FY_USD":3.12,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":16207000000.0,"NetIncomeLoss_4_FY_USD":6994000000.0,"NetIncomeLossConverted_4_FY_USD":7014000000.0,"Revenues_4_FY_USD":46385000000.0,"StockholdersEquity_0_FY_USD":35946000000.0,"StockholdersEquityConverted_0_FY_USD":36006000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":2245000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":2221000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20220209"}]